Truemeds raises USD 5 mn in latest funding round

The funding will be used to expand its footprint to three additional cities, build product and technology and invest in improving the supply chain of generic medicines, Truemeds said in a statement.

Published: 08th June 2021 04:12 PM  |   Last Updated: 08th June 2021 04:12 PM   |  A+A-

Foreign Direct Investment, money, dollar, Indo-US

Image used for representational purpose only (Photo | PTI)

By PTI

NEW DELHI:  Telehealth platform Truemeds on Tuesday said it has closed its USD 5 million (over Rs 35 crore) funding round led by InfoEdge Ventures, Asha Impact and Indian Angel Network Fund.

The funding will be used to expand its footprint to three additional cities, build product and technology and invest in improving the supply chain of generic medicines, Truemeds said in a statement.

This was Series A funding round.

"With this investment, we'll be able to not only make the Truemeds experience even more seamless, but also bring access to affordable medicines to more people in different parts of India," Truemeds Co-founder & CEO Akshat Nayyar said.

Truemeds was founded with a mission to make medicine affordable for chronic patients, he added.

InfoEdge Ventures Partner Amit Behl said, "With this new round, we continue our support for the company as they build further on the proposition to deliver significant savings on healthcare expenses of consumers. 


TAGS
Truemeds

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.